|
|
 |
|
|
 |
|
| Your Result on : Balance Sheet |
 |
|
|
 |
| Dr Lal Pathlabs Ltd |
Industry : Healthcare |
|
|
|
|
|
| Book Value (Rs) |
|
| 147.5167422 |
|
|
|
|
|
|
Market Cap (Rs In Cr.) |
|
| 27,689 |
|
|
|
|
|
|
|
|
|
|
|
|
| Year |
High (Rs) |
Low (Rs) |
Close (Rs) |
P/E High |
P/E Low |
P/E Close |
Mkt Cap.
(Rs In Cr.) |
| Apr 2026 |
1,473.35 |
1,285.00 |
1,368.10 |
50.74 |
41.72 |
45.95 |
22,923.20 |
| Mar 2026 |
1,428.55 |
1,272.00 |
1,313.90 |
48.73 |
41.60 |
44.13 |
22,015.05 |
| Feb 2026 |
1,473.00 |
1,364.00 |
1,398.85 |
50.52 |
44.00 |
46.98 |
23,438.43 |
| Jan 2026 |
1,525.00 |
1,345.80 |
1,408.15 |
52.82 |
43.52 |
47.30 |
23,594.26 |
| Share Prices Of
2025
|
| Dec 2025 |
1,534.05 |
1,349.00 |
1,482.05 |
52.76 |
43.90 |
49.78 |
24,831.90 |
| Nov 2025 |
1,651.48 |
1,511.95 |
1,526.60 |
57.13 |
50.30 |
51.27 |
25,578.34 |
| Oct 2025 |
1,617.53 |
1,503.98 |
1,568.53 |
54.52 |
49.91 |
52.68 |
26,280.80 |
| Sep 2025 |
1,771.30 |
1,551.18 |
1,556.35 |
60.59 |
51.93 |
52.27 |
26,076.80 |
| Aug 2025 |
1,752.03 |
1,537.88 |
1,656.00 |
60.86 |
51.37 |
55.62 |
27,746.45 |
| Jul 2025 |
1,586.13 |
1,370.95 |
1,574.75 |
53.66 |
45.83 |
52.89 |
26,385.10 |
| Jun 2025 |
1,523.80 |
1,365.30 |
1,397.35 |
52.38 |
45.70 |
46.93 |
23,412.74 |
| May 2025 |
1,453.50 |
1,350.38 |
1,394.93 |
49.45 |
44.04 |
46.85 |
23,372.11 |
| Apr 2025 |
1,489.48 |
1,187.50 |
1,383.25 |
51.16 |
37.83 |
46.36 |
23,125.65 |
| Mar 2025 |
1,315.50 |
1,147.55 |
1,239.05 |
45.83 |
37.60 |
41.53 |
20,714.87 |
| Feb 2025 |
1,447.18 |
1,150.00 |
1,154.85 |
71.23 |
55.19 |
55.66 |
19,307.18 |
| Jan 2025 |
1,570.88 |
1,332.70 |
1,425.83 |
76.74 |
63.98 |
68.72 |
23,836.30 |
| Share Prices Of
2024
|
| Dec 2024 |
1,603.45 |
1,439.48 |
1,499.30 |
78.32 |
68.06 |
72.26 |
25,064.62 |
| Nov 2024 |
1,574.75 |
1,458.35 |
1,502.05 |
77.38 |
69.06 |
72.38 |
25,108.04 |
| Oct 2024 |
1,822.50 |
1,505.88 |
1,555.63 |
90.77 |
70.25 |
74.96 |
26,003.59 |
| Sep 2024 |
1,728.63 |
1,604.08 |
1,651.20 |
85.08 |
76.61 |
79.57 |
27,599.56 |
|
| PREV |
NEXT
|
|
|
|
|
|
|
|
|
|